NO912435D0 - Farmasoeytiske preparater. - Google Patents

Farmasoeytiske preparater.

Info

Publication number
NO912435D0
NO912435D0 NO912435A NO912435A NO912435D0 NO 912435 D0 NO912435 D0 NO 912435D0 NO 912435 A NO912435 A NO 912435A NO 912435 A NO912435 A NO 912435A NO 912435 D0 NO912435 D0 NO 912435D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations
androgen
liposomes
preferably used
Prior art date
Application number
NO912435A
Other languages
English (en)
Norwegian (no)
Other versions
NO912435L (no
Inventor
Georg Roessling
Andreas Sachse
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO912435L publication Critical patent/NO912435L/no
Publication of NO912435D0 publication Critical patent/NO912435D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
NO912435A 1989-10-27 1991-06-21 Farmasoeytiske preparater. NO912435D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3936328A DE3936328A1 (de) 1989-10-27 1989-10-27 Pharmazeutische praeparate
PCT/DE1990/000776 WO1991006284A1 (de) 1989-10-27 1990-10-10 Pharmazeutische präparate

Publications (2)

Publication Number Publication Date
NO912435L NO912435L (no) 1991-06-21
NO912435D0 true NO912435D0 (no) 1991-06-21

Family

ID=6392630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912435A NO912435D0 (no) 1989-10-27 1991-06-21 Farmasoeytiske preparater.

Country Status (15)

Country Link
US (1) US5723146A (da)
EP (1) EP0451237B1 (da)
JP (1) JP3011762B2 (da)
AT (1) ATE103804T1 (da)
AU (1) AU6553790A (da)
CA (1) CA2028629C (da)
DE (2) DE3936328A1 (da)
DK (1) DK0451237T3 (da)
FI (1) FI913100A0 (da)
GR (1) GR900100772A (da)
HU (1) HU215127B (da)
IE (1) IE903859A1 (da)
NO (1) NO912435D0 (da)
PT (1) PT95697B (da)
WO (1) WO1991006284A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
DE19916384A1 (de) * 1999-03-31 2000-10-05 Schering Ag Cyproteronacetat, Chlormadinonacetat oder 17alpha-Propylmesterolon enthaltende, bioerosive Mikropartikeln, Verfahren zu deren Herstellung, therapeutische Verwendung dieser in topischen Arzneiformen
JP3466516B2 (ja) 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
EP1316317A1 (fr) * 2001-11-30 2003-06-04 University of Liege Associations hydrosolubles à base de cyprotérone et/ou d'un ester de celle-ci, leurs préparations et leurs utilisations
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
EP1643971A2 (en) * 2003-05-22 2006-04-12 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20050095283A1 (en) * 2003-09-16 2005-05-05 Aphios Corporation Compositions and methods for topically treating diseases
CA2579805A1 (en) * 2004-09-03 2006-03-16 Piedmont Pharmaceuticals, Llc Methods for transmembrane treatment and prevention of otitis media
EP1928439A4 (en) * 2005-09-26 2009-04-29 Piedmont Pharmaceuticals Llc METHOD FOR THE TREATMENT AND PREVENTION OF OTITIS MEDIA WITH CHEMICAL PENETRATION AMPLIFIERS TO FACILITATE THE TRANSMEMBRANOESE DRUG DELIVERY IN THE MIDDLE EAR
JP2009509956A (ja) * 2005-09-26 2009-03-12 ピードモント ファーマシューティカルズ リミテッド ライアビリティ カンパニー 非イオン性界面活性剤を使用して中耳内への経膜的薬物送達を促進する、中耳炎の処置および予防のための方法
DE102006062120A1 (de) 2006-12-22 2008-06-26 Grünenthal GmbH Pharmazeutische Zusammensetzung zur Aknebehandlung
AU2008259226B2 (en) * 2007-05-29 2012-09-27 Pola Chemical Industries, Inc. Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle
EA022208B1 (ru) * 2008-10-10 2015-11-30 Тева Вимен'С Хелс, Инк. Способы лечения вазомоторных симптомов у кастрированных пациентов с раком предстательной железы низкими дозами ципротерона ацетата
ITMI20110644A1 (it) * 2011-04-14 2012-10-15 Giuliani Spa Sistema per il rilascio prolungato di agenti cosmetici

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728364A (en) * 1971-07-27 1973-04-17 Syntex Corp Preparation of 17alpha-propadienyl steroids
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
EP0076158B1 (en) * 1981-09-30 1989-10-25 National Research Development Corporation Compositions comprising encapsulated particles
DE3416978A1 (de) * 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. Durch liposom vermittelte transformation eukaryotischer zellen
EP0240630A3 (en) * 1986-04-10 1989-01-25 University Of Miami Treatment of skin of over androgenicity using compositions containing pregnenolone
AU4805085A (en) * 1984-09-05 1986-03-24 Schering Aktiengesellschaft Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels
IT1199625B (it) * 1985-01-08 1988-12-30 Finchimica Srl Uso terapeutico del ciproterone acetato
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs

Also Published As

Publication number Publication date
NO912435L (no) 1991-06-21
ATE103804T1 (de) 1994-04-15
IE903859A1 (en) 1991-05-08
PT95697A (pt) 1991-09-13
CA2028629C (en) 2000-12-19
FI913100A7 (fi) 1991-06-25
JPH04503676A (ja) 1992-07-02
HUT57590A (en) 1991-12-30
HU907959D0 (en) 1991-11-28
JP3011762B2 (ja) 2000-02-21
AU6553790A (en) 1991-05-02
EP0451237A1 (de) 1991-10-16
DE59005281D1 (de) 1994-05-11
US5723146A (en) 1998-03-03
DK0451237T3 (da) 1994-07-18
WO1991006284A1 (de) 1991-05-16
HU215127B (hu) 1998-09-28
EP0451237B1 (de) 1994-04-06
PT95697B (pt) 1997-09-30
FI913100A0 (fi) 1991-06-25
GR900100772A (el) 1992-03-20
CA2028629A1 (en) 1991-04-28
DE3936328A1 (de) 1991-05-02

Similar Documents

Publication Publication Date Title
FI903382A7 (fi) Tooppisesti annettavat farmaseuttiset valmisteet
DK634787D0 (da) Topiske farmaceutiske praeparater til behandling af acne
NO912435L (no) Farmasoeytiske preparater.
NO922005D0 (no) Farmasoeytiske preparater
IT1243541B (it) Dispositivo di somministrazione in particolare di sostanza farmaceutica
KR880005921A (ko) 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물
FI904092A7 (fi) Lääkevalmisteita ankarien kiputilojen käsittelyyn ja menetelmä niiden valmistamiseksi
NO910340D0 (no) Topiske preparater for behandling av menneskenegler.
DK413987D0 (da) Farmaceutiske praeparater
DK287188D0 (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DE69013557D1 (de) An Liposome gekuppelte bioaktive Verbindungen und ihre Verwendung in pharmazeutischen Zubereitungen.
DK296690D0 (da) Topisk, kosmetisk og farmaceutisk praeparat
DK652787A (da) Farmaceutiske praeparater
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
DK453688D0 (da) Farmaceutiske praeparater til topisk anvendelse
FI950649A7 (fi) Substituoidut sykloheksanoliesterit, niiden käyttö sairauksien hoitamiseksi ja farmaseuttiset valmisteet
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ES2010963A4 (es) Derivados de n - cicloalkilaminoetilbenzamida, su sintesis y preparacion farmaceutica
FR2587217B1 (fr) Preparations pharmaceutiques immunomodulantes
FI874643A0 (fi) Terapeutiska medel och deras anvaendning.
IT8321398A1 (it) Preparazioni farmaceutiche per trattamento topico della cataratta
DK149588A (da) Xylometazolinholdige farmaceutiske praeparater
DK587487A (da) Veterinaerterapeutiske praeparater
ATA256587A (de) Neue cephalosporin-verbindungen sowie diese enthaltende pharmazeutische praeparate